Cargando…
Vaptans and Hyponatremia in Critical Patients
Hyponatremia is the most frequent fluid and electrolyte disorder in hospitalized patients (20%), particularly in ICU, associated with an increase in morbility and mortality. While hypovolaemic hyponatremia needs to be corrected with the replacement of the lost extracellular fluid by isotonic saline,...
Autores principales: | D’Auria, David, Marinosci, Geremia Zito, De Benedictis, Giuseppe, Piazza, Ornella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università di Salerno
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728787/ https://www.ncbi.nlm.nih.gov/pubmed/23905047 |
Ejemplares similares
-
Dopamine Use in Intensive Care: Are We Ready to Turn it Down?
por: Marinosci, Geremia Zito, et al.
Publicado: (2012) -
Vaptans: A new option in the management of hyponatremia
por: Aditya, Suruchi, et al.
Publicado: (2012) -
Unpredictable Nature of Tolvaptan in Treatment of Hypervolemic Hyponatremia: Case Review on Role of Vaptans
por: Malhotra, Ishan, et al.
Publicado: (2014) -
The use of vaptan in hyponatremic patients with liver cirrhosis
por: Choe, Won Hyeok
Publicado: (2011) -
Safety and Efficacy of Vaptans in the Treatment of Hyponatremia from Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): A Systematic Review and Meta-Analysis
por: Krisanapan, Pajaree, et al.
Publicado: (2023)